Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

PRAXVery BullishAnalyst Ratingnews

High materiality9/10

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday

Dec 29, 2025, 10:06 AM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The significant increase in price target suggests high growth expectations for PRAX. A similar instance occurred when price expectations correlated with successful drug trials, leading to price surges.

AI summary

What happened, with direct paths to the underlying reporting

BTIG raised PRAX price target from $507 to $843. PRAX shares closed at $268.95 on Friday. Analyst Kambiz Yazdi maintained a Buy rating for PRAX.

BTIG raised PRAX price target from $507 to $843.
PRAX shares closed at $268.95 on Friday.
Analyst Kambiz Yazdi maintained a Buy rating for PRAX.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.